Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Antibacterial and antioxidant activity of different types of honey derived from Mount Olympus in Greece.

Stagos D, Soulitsiotis N, Tsadila C, Papaeconomou S, Arvanitis C, Ntontos A, Karkanta F, Adamou-Androulaki S, Petrotos K, Spandidos DA, Kouretas D, Mossialos D.

Int J Mol Med. 2018 May 4. doi: 10.3892/ijmm.2018.3656. [Epub ahead of print]

PMID:
29749429
2.

EphA2/Ephrin-A1 Mediate Corneal Epithelial Cell Compartmentalization via ADAM10 Regulation of EGFR Signaling.

Kaplan N, Ventrella R, Peng H, Pal-Ghosh S, Arvanitis C, Rappoport JZ, Mitchell BJ, Stepp MA, Lavker RM, Getsios S.

Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):393-406. doi: 10.1167/iovs.17-22941.

3.

Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors.

Askoxylakis V, Arvanitis CD, Wong CSF, Ferraro GB, Jain RK.

Adv Drug Deliv Rev. 2017 Sep 15;119:159-174. doi: 10.1016/j.addr.2017.06.011. Epub 2017 Jun 22. Review.

PMID:
28648712
4.

Passive Acoustic Mapping with the Angular Spectrum Method.

Arvanitis CD, Crake C, McDannold N, Clement GT.

IEEE Trans Med Imaging. 2017 Apr;36(4):983-993. doi: 10.1109/TMI.2016.2643565. Epub 2016 Dec 21.

5.

Finding chemopreventatives to reduce amyloid beta in yeast.

Macreadie IG, Arvanitis C, Bharadwaj P.

Neural Regen Res. 2016 Feb;11(2):244-5. doi: 10.4103/1673-5374.177729. No abstract available.

6.

Controlled Drug Release and Chemotherapy Response in a Novel Acoustofluidic 3D Tumor Platform.

Zervantonakis IK, Arvanitis CD.

Small. 2016 May;12(19):2616-26. doi: 10.1002/smll.201503342. Epub 2016 Mar 31.

7.

A simple, low-cost staining method for rapid-throughput analysis of tumor spheroids.

Eckerdt F, Alvarez A, Bell J, Arvanitis C, Iqbal A, Arslan AD, Hu B, Cheng SY, Goldman S, Platanias LC.

Biotechniques. 2016 Jan 1;60(1):43-6. doi: 10.2144/000114372. eCollection 2016 Jan.

8.

Targeted, noninvasive blockade of cortical neuronal activity.

McDannold N, Zhang Y, Power C, Arvanitis CD, Vykhodtseva N, Livingstone M.

Sci Rep. 2015 Nov 6;5:16253. doi: 10.1038/srep16253.

9.

Cavitation-enhanced nonthermal ablation in deep brain targets: feasibility in a large animal model.

Arvanitis CD, Vykhodtseva N, Jolesz F, Livingstone M, McDannold N.

J Neurosurg. 2016 May;124(5):1450-9. doi: 10.3171/2015.4.JNS142862. Epub 2015 Sep 18.

10.

Transcranial Assessment and Visualization of Acoustic Cavitation: Modeling and Experimental Validation.

Arvanitis CD, Clement GT, McDannold N.

IEEE Trans Med Imaging. 2015 Jun;34(6):1270-81. doi: 10.1109/TMI.2014.2383835. Epub 2014 Dec 25.

11.

Structure and biomechanics of the endothelial transcellular circumferential invasion array in tumor invasion.

Arvanitis C, Khuon S, Spann R, Ridge KM, Chew TL.

PLoS One. 2014 Feb 24;9(2):e89758. doi: 10.1371/journal.pone.0089758. eCollection 2014.

12.

Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Aryal M, Arvanitis CD, Alexander PM, McDannold N.

Adv Drug Deliv Rev. 2014 Jun;72:94-109. doi: 10.1016/j.addr.2014.01.008. Epub 2014 Jan 22. Review.

13.
14.

Combining virotherapy and angiotherapy for the treatment of breast cancer.

Bazan-Peregrino M, Sainson RC, Carlisle RC, Thoma C, Waters RA, Arvanitis C, Harris AL, Hernandez-Alcoceba R, Seymour LW.

Cancer Gene Ther. 2013 Aug;20(8):461-8. doi: 10.1038/cgt.2013.41. Epub 2013 Jul 12.

PMID:
23846253
15.

Combined ultrasound and MR imaging to guide focused ultrasound therapies in the brain.

Arvanitis CD, Livingstone MS, McDannold N.

Phys Med Biol. 2013 Jul 21;58(14):4749-61. doi: 10.1088/0031-9155/58/14/4749. Epub 2013 Jun 20.

16.

Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.

Bazan-Peregrino M, Rifai B, Carlisle RC, Choi J, Arvanitis CD, Seymour LW, Coussios CC.

J Control Release. 2013 Jul 10;169(1-2):40-7. doi: 10.1016/j.jconrel.2013.03.017. Epub 2013 Apr 4.

PMID:
23562636
17.

A non-exothermic cell-embedding tissue-mimicking material for studies of ultrasound-induced hyperthermia and drug release.

Mylonopoulou E, Bazán-Peregrino M, Arvanitis CD, Coussios CC.

Int J Hyperthermia. 2013;29(2):133-44. doi: 10.3109/02656736.2012.762553. Epub 2013 Feb 13.

PMID:
23406389
18.

Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring.

Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N.

PLoS One. 2012;7(9):e45783. doi: 10.1371/journal.pone.0045783. Epub 2012 Sep 24.

19.

Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques.

McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS.

Cancer Res. 2012 Jul 15;72(14):3652-63. doi: 10.1158/0008-5472.CAN-12-0128. Epub 2012 May 2.

20.

Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model.

Bazan-Peregrino M, Arvanitis CD, Rifai B, Seymour LW, Coussios CC.

J Control Release. 2012 Jan 30;157(2):235-42. doi: 10.1016/j.jconrel.2011.09.086. Epub 2011 Oct 1.

PMID:
21982902
21.

Cavitation-enhanced extravasation for drug delivery.

Arvanitis CD, Bazan-Peregrino M, Rifai B, Seymour LW, Coussios CC.

Ultrasound Med Biol. 2011 Nov;37(11):1838-52. doi: 10.1016/j.ultrasmedbio.2011.08.004. Epub 2011 Oct 2.

PMID:
21963037
22.

Cavitation-enhanced delivery of macromolecules into an obstructed vessel.

Rifai B, Arvanitis CD, Bazan-Peregrino M, Coussios CC.

J Acoust Soc Am. 2010 Nov;128(5):EL310-15. doi: 10.1121/1.3496388.

PMID:
21110544
23.

Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp.

Pichot CS, Arvanitis C, Hartig SM, Jensen SA, Bechill J, Marzouk S, Yu J, Frost JA, Corey SJ.

Cancer Res. 2010 Nov 1;70(21):8347-56. doi: 10.1158/0008-5472.CAN-09-4149. Epub 2010 Oct 12.

24.

Quantitative contrast-enhanced mammography for contrast medium kinetics studies.

Arvanitis CD, Speller R.

Phys Med Biol. 2009 Oct 21;54(20):6041-64. doi: 10.1088/0031-9155/54/20/002. Epub 2009 Sep 24.

PMID:
19779213
25.

Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.

Pichot CS, Hartig SM, Xia L, Arvanitis C, Monisvais D, Lee FY, Frost JA, Corey SJ.

Br J Cancer. 2009 Jul 7;101(1):38-47. doi: 10.1038/sj.bjc.6605101. Epub 2009 Jun 9.

26.

Signal and noise transfer properties of CMOS based active pixel flat panel imager coupled to structured CsI:Tl.

Arvanitis CD, Bohndiek SE, Blakesley J, Olivo A, Speller RD.

Med Phys. 2009 Jan;36(1):116-26.

PMID:
19235380
27.

(18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation.

Arvanitis C, Bendapudi PK, Tseng JR, Gambhir SS, Felsher DW.

Cancer Biol Ther. 2008 Dec;7(12):1947-51. Epub 2008 Dec 7.

28.

Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis.

Wu CH, Sahoo D, Arvanitis C, Bradon N, Dill DL, Felsher DW.

PLoS Genet. 2008 Jun 6;4(6):e1000090. doi: 10.1371/journal.pgen.1000090. Erratum in: PLoS Genet. 2013 Oct;9(10). doi:10.1371/annotation/a0e06cef-a7e4-4ec9-9f35-9df5e50bf7a2.

29.

A CMOS active pixel sensor system for laboratory- based x-ray diffraction studies of biological tissue.

Bohndiek SE, Cook EJ, Arvanitis CD, Olivo A, Royle GJ, Clark AT, Prydderch ML, Turchetta R, Speller RD.

Phys Med Biol. 2008 Feb 7;53(3):655-72. doi: 10.1088/0031-9155/53/3/010. Epub 2008 Jan 10.

PMID:
18199908
30.

Empirical electro-optical and x-ray performance evaluation of CMOS active pixels sensor for low dose, high resolution x-ray medical imaging.

Arvanitis CD, Bohndiek SE, Royle G, Blue A, Liang HX, Clark A, Prydderch M, Turchetta R, Speller R.

Med Phys. 2007 Dec;34(12):4612-25.

PMID:
18196789
31.

Identifying critical signaling molecules for the treatment of cancer.

Arvanitis C, Bendapudi PK, Bachireddy P, Felsher DW.

Recent Results Cancer Res. 2007;172:5-24. Review. No abstract available.

PMID:
17607933
32.

Conditional transgenic models define how MYC initiates and maintains tumorigenesis.

Arvanitis C, Felsher DW.

Semin Cancer Biol. 2006 Aug;16(4):313-7. Epub 2006 Jul 21. Review.

PMID:
16935001
33.

Conditionally MYC: insights from novel transgenic models.

Arvanitis C, Felsher DW.

Cancer Lett. 2005 Aug 26;226(2):95-9. Epub 2004 Dec 16. Review.

PMID:
16039948
34.

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.

Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Felsher DW.

Nature. 2004 Oct 28;431(7012):1112-7. Epub 2004 Oct 10.

35.

Developmental context determines latency of MYC-induced tumorigenesis.

Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW.

PLoS Biol. 2004 Nov;2(11):e332. Epub 2004 Sep 28.

36.

Sustained loss of a neoplastic phenotype by brief inactivation of MYC.

Jain M, Arvanitis C, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, Bishop JM, Felsher DW.

Science. 2002 Jul 5;297(5578):102-4.

37.

Convergence of the optimized delta expansion for the connected vacuum amplitude: Anharmonic oscillator.

Arvanitis C, Jones HF, Parker CS.

Phys Rev D Part Fields. 1995 Sep 15;52(6):3704-3711. No abstract available.

PMID:
10019591
38.

Calcifying aponeurotic fibroma.

Rangwala AF, Bateyko R, Sacco M, Arvanitis C.

N J Med. 1988 Sep;85(9):729-30. No abstract available.

PMID:
2976134
39.

Molecular organization of gallstones.

Potamitis GS, Tsonis PA, Arvanitis C.

Dig Dis Sci. 1987 Mar;32(3):332. No abstract available. Erratum in: Dig Dis Sci 1988 Aug;33(8):1055.

PMID:
3816487
40.

Experimental and clinical attempts at correction of interventricular septal defects.

BAILEY CP, LACY MH, NEPTUNE WB, WELLER R, ARVANITIS CS, KARASIC J.

Ann Surg. 1952 Dec;136(6):919-36. No abstract available.

Supplemental Content

Loading ...
Support Center